In studies carried out in mice and humans, it was observed that the shortening of telomeres accelerated aging, and in patients with AD, these alterations are associated with a cognitive deficit, β-amyloid aggregates, and phosphorylated tau associated with oxidative and inflammatory processes (Herrmann et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.